Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Plos Pathogens
|
October 17, 2013
Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody
Kai Xu, Barry Rockx, Yihu Xie, et al.
The Journal of Experimental Medicine
|
August 10, 2016
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth
Lakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.
Human Immunology
|
February 28, 2021
Administration of high titer convalescent anti-SARS-CoV-2 plasma: From donor selection to monitoring recipient outcomes
Rachelle P Mendoza, William Fyke, David Daniel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2023
A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy
Amr El Zawily, Frederick S Vizeacoumar, Renuka Dahiya, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Plos Pathogens
|
October 17, 2013
Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody
Kai Xu, Barry Rockx, Yihu Xie, et al.
The Journal of Experimental Medicine
|
August 10, 2016
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth
Lakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.
Human Immunology
|
February 28, 2021
Administration of high titer convalescent anti-SARS-CoV-2 plasma: From donor selection to monitoring recipient outcomes
Rachelle P Mendoza, William Fyke, David Daniel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2023
A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy
Amr El Zawily, Frederick S Vizeacoumar, Renuka Dahiya, et al.
Page
of 8